EN DE

Cross Country Healthcare, Inc (CCRN) Fair Value & Analysis

Healthcare · US · Market cap $425M

CC Cross Country Healthcare, Inc logo Cross Country Healthcare, Inc CCRN · US
Price$13.25
Fair Value$9.07
Upside-31.6%
Quality61/100
Watch Cross Country Healthcare, Inc for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -9.8% net margin
Low debt · generates free cash flow
Trails peers (3/13)
Narrow moat 13/100
Evidence: Medium Range $7.63 – $10.52 Share as image

Fair value as of: Jul 15, 2026

From 12 valuation models · updated 26 days ago

Fair value updated Jul 15, 2026, revised from $16.28 to $9.07 (−44.3%) since Jun 24, 2026. Share price +0.4% over the past month.

A solid business, but screening 32% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case ($10.52). The favourable scenario is already priced in.
  • Solid but not exceptional quality (61/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$38.10 $7.53 Fair Value $9.07 Apr 2021 Jul 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 15, 2026.

How to read this chart

60‑month range $7.53 – $38.10 · fair‑value band $7.63 – $10.52 · the $13.25 price screens above the $9.07 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 15, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Cross Country Healthcare, Inc (CCRN) currently trades at $13.25, while our model-based Fair Value estimate is $9.07, implying the stock looks roughly 31.6% overvalued today. The Quality Score stands at 61/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Cross Country Healthcare, Inc generated revenue of $1.0B at a net margin of -9.8%. Revenue declined 17.8% year over year. It earns a return on equity of -27.0%. The balance sheet holds a net cash position of $106M. Fundamentals as of Jul 15, 2026

Our scenario range runs from $7.63 (bear case) to $10.52 (bull case); at $13.25, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 12% below its 52-week high and 78% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -32%, CCRN screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF $9.96 $13.48 $17.67 80
Rev-Margin DCF $9.51 $14.88 $20.67 74
Gordon GGM $0.2800 $0.4400 $0.6000 70
All 12 models by family
DCF Models
FCF DCF $9.78 $13.66 $18.49 38
5Y Revenue Exit $9.51 $14.73 $21.13 39
5Y EBITDA Exit $5.54 $7.67 $9.94 41
10Y Revenue Exit $9.24 $13.65 $19.05 36
10Y EBITDA Exit $7.25 $9.28 $11.58 37
Dividend Discount
Gordon GGM $0.2800 $0.4400 $0.6000 70
DDM Multi-Stage $0.2800 $0.3900 $0.5000 61
Multiples
EV/EBITDA $3.10 $4.54 $5.98 54
EV/Revenue $10.05 $14.89 $19.73 43
Asset-Based
NCAV (Graham) $5.00 $6.69 $9.99 50
Growth DCF
Growth DCF $9.96 $13.48 $17.67 80
Rev-Margin DCF $9.51 $14.88 $20.67 74

Widest divergence: DCF Models ($13.65) versus Dividend Discount ($0.3900). Highest evidence: Growth DCF (80).

Notify me when CCRN reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $1.0B
Revenue growth (YoY) -17.8%
Net margin -9.8%
Return on equity -27.0%
Free cash flow $40.1M FY2025
Operating margin -0.8%
More key figures
EPS (TTM) $-3.05
EPS growth (YoY) -78.5%
Net cash $106M FY2025

Figures from reported company fundamentals · as of Jul 15, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 61/100

Of which business quality 63 · Market factors (momentum, volatility) 65

Profitability 36
Margins and returns on capital today
Quality Growth 23
Are margins and returns improving?
Cashflow 46
Earnings quality: real cash, not paper profit
Fin. Strength 89
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 57
Calm price path (market factor)
Momentum 75
Price trend over the last 3–12 months (market factor)
52W Momentum 58
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments: Nurse and Allied Staffing, and Physician Staffing.

Full company description

Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel nurse and allied professionals, per diem, and healthcare leaders within nursing, allied, human resources, and finance; vendor neutral and managed services programs; and education healthcare, caregiver services, and outsourcing services. This segment offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term assignments, as well as workforce solutions, including MSP, VMS, RPO, project management, and other outsourcing and consultative services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. The company serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, correctional facilities, PACE programs, physician practice groups, and other healthcare providers. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments. This segment serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Cross Country Healthcare, Inc reported revenue of $1.1B in FY2025 versus $1.7B in FY2021, a compound −11.0%/yr. Reported net income was −$94.9M in FY2025.

Growth Quality 34/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$1.1B
Latest YoY
−21.6%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−27.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.7%
Avg. growth/yr (26Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.7%
Revenue −11.0%/yr
FY21 $1.7B
FY22 $2.8B
FY23 $2.0B
FY24 $1.3B
FY25 $1.1B
Net income
FY21 $132M
FY22 $186M
FY23 $72.6M
FY24 −$14.6M
FY25 −$94.9M

CCRN screens 32% overvalued. Compare with HCA Healthcare, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Cross Country Healthcare, Inc Fair Value". https://www.fairvalue-calculator.com/stock/CCRN

Earlier news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Medical Care Facilities · 261 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 61 · Above median
Fair Value upside −32% · Below median
Return on assets -0% · Bottom 25%
Net margin (TTM) -10% · Bottom 25%
Operating margin (TTM) -1% · Bottom 25%
Revenue growth -18% · Bottom 25%
Debt / equity 0.46× · Higher than median

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/B 1.32× · Cheaper than median
P/S (TTM) 0.43× · Cheaper than 75% of peers
P/FCF 10.6× · Pricier than 75% of peers
EV/EBITDA 33.0× · Pricier than 75% of peers
PEG 12.54× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 23
FUTURE 0 · sector 24
PAST 0 · sector 30
HEALTH 77 · sector 90
DIVIDEND 0 · sector 38

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $378.85 $554.93 +46%
Fresenius SE FRE €41.73 €32.15 -23%
Dr. Sulaiman Al Habib Medical Services Group 4013 235.00 SAR 112.37 SAR -52%
IHH Healthcare Berhad, an investment holding company, Q0F 2.58 SGD 1.44 SGD -44%
Tenet Healthcare Corporation THC $194.91 $338.05 +73%
Rede D'Or São Luiz S.A RDOR3 R$36.01 R$47.31 +31%
DaVita Inc DVA $231.61 $255.97 +11%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,955 ₹2,955 -67%
Fresenius Medical Care AG FMS $24.68 $45.60 +85%
Aier Eye Hospital Group 300015 ¥8.68 ¥7.67 -12%

Compare Cross Country Healthcare, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Cross Country Healthcare, Inc (CCRN) overvalued or undervalued?
As of Jul 15, 2026, our model estimates a fair value of $9.07 versus a price of $13.25, about −32% (overvalued).
What is the fair value of CCRN?
Our model-based fair value for Cross Country Healthcare, Inc is $9.07 (as of Jul 15, 2026), built from audited fundamentals. The current price is $13.25.
What is the quality score of CCRN?
Cross Country Healthcare, Inc has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Cross Country Healthcare, Inc (CCRN)?
Cross Country Healthcare, Inc reported trailing-twelve-month revenue of about $1.0B (latest available figure, as of Jul 15, 2026).
What is the net profit margin of CCRN?
The net profit margin of Cross Country Healthcare, Inc is about -9.8%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Cross Country Healthcare, Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.